This content is machine translated Atrial fibrillation and secondary prevention after stroke Status of the new anticoagulants In primary and secondary prevention in patients with atrial fibrillation (AF), after a long period of monopoly of vitamin K antagonists (VKA), new agents such as dabigatran, rivaroxaban, and apixaban…
